News
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 10, 2020Clinical Stage Cell Therapy Company Reports Concurrent Modulation of T Regulatory Cells and Tolerogenic Dendritic Cells using Adoptive Cellular Therapy
Creative Medical Technology Holdings trading under the ticker symbol CELZ announced today its patent filing based on data covering utilization of the Company's ImmCelz ® product at generating...
-
Sep 29, 2020Commercial Stage Stem Cell Company Achieves Selective Reprogramming of Pathological Autoimmunity
(OTC-CELZ) -- Creative Medical Technology Holdings announced today proof of concept studies demonstrating efficacy of its ImmCelz ® immunotherapy product in the collage induced model of...
-
Sep 24, 2020
(OTC-CELZ) Creative Medical Technology Holdings, Inc. announced today an update of its corporate activities. CaverStemR: Recruitment and training of physicians on the CaverStemR program for the...
-
Sep 8, 2020Commercial Stage Stem Cell Company Receives Second Patent Issuance Covering Cell Therapies for Disc Inflammation and Degeneration
(OTC – CELZ) -- Creative Medical Technology Holdings Inc. announced today receipt of a Notice of Allowance from the United States Patent and Trademark Office for its patent application,...
-
Aug 20, 2020New Data Supports Current Push for FDA Clearance of Universal Donor Amniotic Fluid Derived Stem Cell Product
Creative Medical Technology Holdings Inc., trading under the ticker symbol CELZ, announced today new data demonstrating effective suppression of stroke associated pathological molecules by...
-
Jul 9, 2020Company Completes Critical Milestone in Development of "Universal Donor" Stem Cell Therapy for Stroke
(OTC-CELZ) Creative Medical Technology Holdings announced today completion of preclinical studies assessing the anti-inflammatory and neuroregenerative activities of AmnioStem™. These studies...
-
Apr 20, 2020Broad Claims Cover Entire Class of Adult Stem Cells for Treatment of Ovarian Failure
Creative Medical Technology Holdings Inc. (OTC-CELZ) announced today receipt of a Quayle Action on its patent application #15/652213 entitled Methods for Treatment of Premature Ovarian Failure and...
-
Mar 11, 2020Clinical Stage Adult Stem Cell Therapy Company Discovers New Way to Stop Immune Diseases without Immune Suppression
Creative Medical Technology Holdings announced today, what appears to be, the first personalized adoptive immunotherapy for treatment of autoimmunity, which the Company named "IMMCELZ™"....
-
Feb 13, 2020
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Orthopedics and Neurology using adult stem cell treatments, today...
-
Jan 15, 2020
Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading commercial stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced...